Latest Conference Articles

Dr Christine Ko: “COVID Toes” Not Active Skin Infection

Dr Christine Ko: “COVID Toes” Not Active Skin Infection

April 25th 2021, 2:00pm

AAD: American Academy of Dermatology

There is likely not directly infectious replicating skin in a condition known as "COVID toes," and that’s important to reassure patients, said Christine Ko, MD, professor of dermatology and pathology at Yale University.

Dr Lawrence F. Eichenfield on Advancements in Atopic Dermatitis Among Adolescents

Dr Lawrence F. Eichenfield on Advancements in Atopic Dermatitis Among Adolescents

April 25th 2021, 12:00pm

AAD: American Academy of Dermatology

Patients want better control of their atopic dermatitis, and we don’t want them to acquiesce to their disease, explained Lawrence F. Eichenfield, MD, chief of pediatric and adolescent dermatology at Rady Children's Hospital-San Diego.

Dr Rajiv Nijhawan: Immunosuppression Increases Skin Cancer Risk Among Transplant Patients

Dr Rajiv Nijhawan: Immunosuppression Increases Skin Cancer Risk Among Transplant Patients

April 24th 2021, 2:00pm

AAD: American Academy of Dermatology

With immunosuppression, self-regulatory mechanisms may start to decrease, and these are the patients who develop skin cancers more frequently, said Rajiv Nijhawan, MD, UT Southwestern Medical Center.

Regardless of Previous Medications, Baseline Characteristics, Ruxolitinib Cream Is Effective in AD

Regardless of Previous Medications, Baseline Characteristics, Ruxolitinib Cream Is Effective in AD

April 24th 2021, 1:00pm

AAD: American Academy of Dermatology

Posters presented at the American Academy of Dermatology Virtual Meeting Experience show ruxolitinib cream was effective at treating atopic dermatitis (AD) regardless of previous treatments and in patients with more severe disease.

Dr Andy Blauvelt Talks Pruritus, Improvements Seen With Ruxolitinib Cream

Dr Andy Blauvelt Talks Pruritus, Improvements Seen With Ruxolitinib Cream

April 24th 2021, 12:00pm

AAD: American Academy of Dermatology

Topical application of ruxolitinib cream significantly, and rapidly, decreases pruritus, noted Andy Blauvelt, MD, MBA, dermatologist and clinical study investigator at Oregon Medical Research Center, a dedicated clinical trial site.

Despite Expanding Array of Psoriasis Treatments, Opportunities for Improvement Remain

Despite Expanding Array of Psoriasis Treatments, Opportunities for Improvement Remain

April 23rd 2021, 9:00pm

NAMCP: National Association of Managed Care Physicians Forum

There are a number of new biologic options for treating psoriasis, but undertreatment is still a concern, and more long-term data are needed, according to Junko Takeshita, MD, PhD, MSCE, at the National Association of Managed Care Physicians Virtual Spring Managed Care Forum.

New Understanding of Migraine Biology Paves Way for Innovative Therapy Options

New Understanding of Migraine Biology Paves Way for Innovative Therapy Options

April 23rd 2021, 8:34pm

NAMCP: National Association of Managed Care Physicians Forum

Now that investigators have a better understanding of the biological mechanisms of migraine, new treatment and prevention options are making their way to patients and fueling an exciting time for the field, according to a presenter at the National Association of Managed Care Physicians Virtual Spring Managed Care Forum.

Overcoming the Unique Hurdles to Biosimilar Uptake in Oncology

Overcoming the Unique Hurdles to Biosimilar Uptake in Oncology

April 23rd 2021, 5:39pm

NAMCP: National Association of Managed Care Physicians Forum

With the costs of biologic drugs increasing, biosimilars have emerged as an attractive option for containing costs and expanding access to treatment. However, some barriers to wider uptake still need to be addressed, according to a presentation at the National Association of Managed Care Physicians Virtual Spring Managed Care Forum.

Ruxolitinib Cream Successfully Treats Itch in AD, Is Safe and Effective in Adolescents

Ruxolitinib Cream Successfully Treats Itch in AD, Is Safe and Effective in Adolescents

April 23rd 2021, 2:00pm

AAD: American Academy of Dermatology

Patients with atopic dermatitis (AD) who received ruxolitinib cream experienced a rapid, clinically meaningful, and sustained improvement in their itch.

Dr Todd Schlesinger Discusses Treatments for Advanced Skin Cancers

Dr Todd Schlesinger Discusses Treatments for Advanced Skin Cancers

April 23rd 2021, 2:00pm

AAD: American Academy of Dermatology

For cases of advanced skin cancer that are not candidates for surgery or radiation therapy, we have Hedgehog pathway inhibitors and PD-1 inhibitors, each of which has 2 approved medications, noted Todd Schlesinger, MD, FAAD.